Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology

被引:146
作者
George, Maya [1 ]
Ghosh, Indrajit [2 ]
机构
[1] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[2] Novartis Pharmaceut, Pharmaceut Dev Unit, E Hanover, NJ 07936 USA
关键词
Media mill; Nanosuspension; Enthalpy; Zeta potential; Solubility; Stabilizer; POORLY SOLUBLE DRUGS; DISSOLUTION RATE ENHANCEMENT; SOLUBILITY; NANOCRYSTALS; DELIVERY; STABILIZATION;
D O I
10.1016/j.ejps.2012.10.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Wet media milling by top down method has proved to be an effective method to prepare nanosuspension of poorly soluble drugs/APIs. Few or no attempts have been made so far to understand the feasibility of nanosuspension formulation in terms of the mechanism of stabilization as a function of drug properties. The objective of this study was to understand the effect of drug substance and stabilizer properties to form a successful nanosuspension product. From this study, logP and enthalpy were concluded to have a direct correlation on the feasibility of formation of a stable nanosuspension. The most likely candidate for media milling was a drug substance with a high enthalpy and hydrophobicity which can be stabilized either electrostatically or sterically. The least likely candidate will be one that is hydrophilic and having a very low enthalpy value. Also the choice of an ideal stabilizer/surfactant was found to be influenced by the degree of hydrophobicity of the drug itself. Finally the morphology of the starting drug was found to significantly affect the milling time required to produce submicron particles. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:142 / 152
页数:11
相关论文
共 39 条
[1]   At decision-support tool for the formulation of orally active, poorly soluble compounds [J].
Branchu, Sebastien ;
Roqueda, Philippe G. ;
Plumb, A. Philip ;
Cook, Walter G. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 32 (02) :128-139
[2]   Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement [J].
Branham, Michael Lee ;
Moyo, Thomas ;
Govender, Thirumala .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 80 (01) :194-202
[3]  
Castro CL., 2002, SYNTHESIS FUNCTIONAL, P1
[4]  
Cerdeira A.-M., 2012, INT J PHARMACEUT, V396, P210
[5]   Lipid - An emerging platform for oral delivery of drugs with poor bioavailability [J].
Chakraborty, Subhashis ;
Shukla, Dali ;
Mishra, Brahmeshwar ;
Singh, Sanjay .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 73 (01) :1-15
[6]   Role of polymeric stabilizers for drug nanocrystal dispersions [J].
Choi, JY ;
Yoo, JY ;
Kwak, HS ;
Nam, BU ;
Lee, J .
CURRENT APPLIED PHYSICS, 2005, 5 (05) :472-474
[7]  
Ghosh I., 2012, EUR J PHARM SCI
[8]   Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth [J].
Ghosh, Indrajit ;
Bose, Sonali ;
Vippagunta, Radha ;
Harmon, Ferris .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 409 (1-2) :260-268
[9]   Nanosuspensions of poorly soluble drugs -: reproducibility of small scale production [J].
Grau, MJ ;
Kayser, O ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) :155-159
[10]   Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base [J].
Hecq, J. ;
Deleers, M. ;
Fanara, D. ;
Vranckx, H. ;
Boulanger, P. ;
Le Lamer, S. ;
Amighi, K. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (03) :360-368